Dr. Jeffrey Weber on Potential Breakthrough “Cures” in Melanoma

http://youtu.be/wsaq6Pw0lZk Weber says these treatments, such as ipilimumab plus nivolumab, or dabrafenib and trametinib, have seen marked improvements since 2009, and continue to become more important in the treatment paradigm of melanoma. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/